Association between lung cancer somatic mutations and occupational exposure in never-smokers

Eur Respir J. 2017 Oct 26;50(4):1700716. doi: 10.1183/13993003.00716-2017. Print 2017 Oct.

Abstract

Occupational exposure constitutes a common risk factor for lung cancer. We observed molecular alterations in 73% of never-smokers, 35% of men and 8% of women were exposed to at least one occupational carcinogen. We report herein associations between molecular patterns and occupational exposure.BioCAST was a cohort study of lung cancer in never-smokers that reported risk factor exposure and molecular patterns. Occupational exposure was assessed via a validated 71-item questionnaire. Patients were categorised into groups that were unexposed and exposed to polycyclic aromatic hydrocarbons (PAH), asbestos, silica, diesel exhaust fumes (DEF), chrome and paints. Test results were recorded for EGFR, KRAS, HER2, BRAF and PIK3 mutations, and ALK alterations.Overall, 313 out of 384 patients included in BioCAST were analysed. Asbestos-exposed patients displayed a significantly lower rate of EGFR mutations (20% versus 44%, p=0.033), and a higher rate of HER2 mutations (18% versus 4%, p=0.084). ALK alterations were not associated with any occupational carcinogens. The DEF-exposed patients were diagnosed with a BRAF mutation in 25% of all cases. Chrome-exposed patients exhibited enhanced HER2 and PIK3 mutation frequency.Given its minimal effects in the subgroups, we conclude that occupational exposure slightly affects the molecular pattern of lung cancers in never-smokers. In particular, asbestos-exposed patients have a lower chance of EGFR mutations.

Trial registration: ClinicalTrials.gov NCT01465854.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adenocarcinoma / etiology
  • Adenocarcinoma / genetics*
  • Aged
  • Aged, 80 and over
  • Asbestos / adverse effects
  • Biomarkers, Tumor / genetics*
  • ErbB Receptors / genetics
  • Female
  • France
  • Gasoline / adverse effects
  • Humans
  • Logistic Models
  • Lung Neoplasms / etiology
  • Lung Neoplasms / genetics*
  • Male
  • Middle Aged
  • Mutation
  • Occupational Exposure / adverse effects*
  • Prospective Studies
  • Proto-Oncogene Proteins B-raf / genetics
  • Receptor, ErbB-2 / genetics
  • Risk Factors
  • Smoking / epidemiology

Substances

  • Biomarkers, Tumor
  • Gasoline
  • Asbestos
  • EGFR protein, human
  • ERBB2 protein, human
  • ErbB Receptors
  • Receptor, ErbB-2
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf

Associated data

  • ClinicalTrials.gov/NCT01465854